These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34837010)

  • 1. Structural, energetic and lipophilic analysis of SARS-CoV-2 non-structural protein 9 (NSP9).
    de O Araújo J; Pinheiro S; Zamora WJ; Alves CN; Lameira J; Lima AH
    Sci Rep; 2021 Nov; 11(1):23003. PubMed ID: 34837010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimerization of Coronavirus nsp9 with Diverse Modes Enhances Its Nucleic Acid Binding Affinity.
    Zeng Z; Deng F; Shi K; Ye G; Wang G; Fang L; Xiao S; Fu Z; Peng G
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Backbone chemical shift assignments for the SARS-CoV-2 non-structural protein Nsp9: intermediate (ms - μs) dynamics in the C-terminal helix at the dimer interface.
    Buchko GW; Zhou M; Craig JK; Van Voorhis WC; Myler PJ
    Biomol NMR Assign; 2021 Apr; 15(1):107-116. PubMed ID: 33392924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Biochemical and Biophysical Analysis of the Interaction of nsp9 with nsp12 from SARS-CoV-2-Implications for Future Drug Discovery Efforts.
    Baker DL; Wang B; Wilkinson-White LE; El-Kamand S; Allport TA; Ataide SF; Kwan AH; Artsimovitch I; Cubeddu L; Gamsjaeger R
    Proteins; 2024 Nov; 92(11):1308-1317. PubMed ID: 38958516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interface design of SARS-CoV-2 symmetrical nsp7 dimer and machine learning-guided nsp7 sequence prediction reveals physicochemical properties and hotspots for nsp7 stability, adaptation, and therapeutic design.
    Yadav AJ; Kumar S; Maurya S; Bhagat K; Padhi AK
    Phys Chem Chem Phys; 2024 May; 26(18):14046-14061. PubMed ID: 38686454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing nanobody interaction with SARS-CoV-2 Nsp9.
    Esposito G; Hunashal Y; Percipalle M; Fogolari F; Venit T; Leonchiks A; Gunsalus KC; Piano F; Percipalle P
    PLoS One; 2024; 19(5):e0303839. PubMed ID: 38758765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A distinct ssDNA/RNA binding interface in the Nsp9 protein from SARS-CoV-2.
    El-Kamand S; Du Plessis MD; Breen N; Johnson L; Beard S; Kwan AH; Richard DJ; Cubeddu L; Gamsjaeger R
    Proteins; 2022 Jan; 90(1):176-185. PubMed ID: 34369011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable oligomerization modes in coronavirus non-structural protein 9.
    Ponnusamy R; Moll R; Weimar T; Mesters JR; Hilgenfeld R
    J Mol Biol; 2008 Nov; 383(5):1081-96. PubMed ID: 18694760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe acute respiratory syndrome coronavirus nsp9 dimerization is essential for efficient viral growth.
    Miknis ZJ; Donaldson EF; Umland TC; Rimmer RA; Baric RS; Schultz LW
    J Virol; 2009 Apr; 83(7):3007-18. PubMed ID: 19153232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A natural product compound inhibits coronaviral replication in vitro by binding to the conserved Nsp9 SARS-CoV-2 protein.
    Littler DR; Liu M; McAuley JL; Lowery SA; Illing PT; Gully BS; Purcell AW; Chandrashekaran IR; Perlman S; Purcell DFJ; Quinn RJ; Rossjohn J
    J Biol Chem; 2021 Dec; 297(6):101362. PubMed ID: 34756886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A structural analysis of the nsp9 protein from the coronavirus MERS CoV reveals a conserved RNA binding interface.
    Mani G; El-Kamand S; Wang B; Baker DL; Ataide SF; Artsimovitch I; Cubeddu L; Gamsjaeger R
    Proteins; 2024 Mar; 92(3):418-426. PubMed ID: 37929701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NSP9 of SARS-CoV-2 attenuates nuclear transport by hampering nucleoporin 62 dynamics and functions in host cells.
    Makiyama K; Hazawa M; Kobayashi A; Lim K; Voon DC; Wong RW
    Biochem Biophys Res Commun; 2022 Jan; 586():137-142. PubMed ID: 34844119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for dimerization and RNA binding of avian infectious bronchitis virus nsp9.
    Hu T; Chen C; Li H; Dou Y; Zhou M; Lu D; Zong Q; Li Y; Yang C; Zhong Z; Singh N; Hu H; Zhang R; Yang H; Su D
    Protein Sci; 2017 May; 26(5):1037-1048. PubMed ID: 28257598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional effects of the L84S mutant in the SARS-COV-2 ORF8 dimer based on microsecond molecular dynamics study.
    Islam S; Parves MR; Islam MJ; Ali MA; Efaz FM; Hossain MS; Ullah MO; Halim MA
    J Biomol Struct Dyn; 2024 Jul; 42(11):5770-5787. PubMed ID: 37403295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based drug repurposing for targeting Nsp9 replicase and spike proteins of severe acute respiratory syndrome coronavirus 2.
    Chandel V; Sharma PP; Raj S; Choudhari R; Rathi B; Kumar D
    J Biomol Struct Dyn; 2022 Jan; 40(1):249-262. PubMed ID: 32838660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMR-Based Analysis of Nanobodies to SARS-CoV-2 Nsp9 Reveals a Possible Antiviral Strategy Against COVID-19.
    Esposito G; Hunashal Y; Percipalle M; Venit T; Dieng MM; Fogolari F; Hassanzadeh G; Piano F; Gunsalus KC; Idaghdour Y; Percipalle P
    Adv Biol (Weinh); 2021 Dec; 5(12):e2101113. PubMed ID: 34705339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of SARS-CoV-2 Nsp9 ssDNA-Binding Activity and Cytotoxic Effects on H838, H1975, and A549 Human Non-Small Cell Lung Cancer Cells: Exploring the Potential of
    Su HH; Lin ES; Huang YH; Lien Y; Huang CY
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
    Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
    J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico evaluation of lapachol derivatives binding to the Nsp9 of SARS-CoV-2.
    Junior NN; Santos IA; Meireles BA; Nicolau MSP; Lapa IR; Aguiar RS; Jardim ACG; José DP
    J Biomol Struct Dyn; 2022 Aug; 40(13):5917-5931. PubMed ID: 33478342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and energetic features of the dimerization of the main proteinase of SARS-CoV-2 using molecular dynamic simulations.
    Zhang Y; Zheng L; Yang Y; Qu Y; Li YQ; Zhao M; Mu Y; Li W
    Phys Chem Chem Phys; 2022 Feb; 24(7):4324-4333. PubMed ID: 35107451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.